A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.
Clinical trial NCT05656274 · COMPLETED
Trial details
- NCT number
- NCT05656274
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-29
- Primary completion
- 2023-07-24
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.